An overview of the
current data from PsoProtectMe

Current Data

We are committed to sharing data and are delighted to provide open access to summary information from PsoProtectMe. These data are preliminary and include a limited number of participants, so should not be used to inform clinical decision making.

Click here to read our scientific research paper detailing PsoProtect data. A summary of this research can be found on the Psoriasis Association website here.

Our scientific research paper detailing shielding behaviour can be found here. A summary can also be found on the Psoriasis Association website here.

PsoProtectMe surveys completed

Summary data from PsoProtectMe’s first 3787 participants.

Participants per country (≥10 participants):

Country Participants Country Participants
Argentina 79 Netherlands 26
Australia 37 Norway 17
Brazil 30 Panama 11
Canada 52 Peru 16
Chile 216 Philippines 56
Denmark 51 Poland 65
Greece 11 Portugal 203
Hong Kong 18 Singapore 13
India 30 Spain 71
Ireland 57 Sweden 39
Italy 33 United Kingdom 2110
Japan 97 United States 276
Malaysia 10 Other (<10) 163

Average age: 46 years (range 3-91)

Average BMI: 26.8 kg/m2

Type of psoriasis: 3178 plaque psoriasis, 807 guttate psoriasis, 212 pustular psoriasis, 76 erythrodema


Smoking status:

Coexisting psoriatic arthritis:

Type of psoriasis treatment:

Psoriasis severity change during the pandemic:

Have you been diagnosed with or thought you had COVID-19?

Did you go to hospital A&E due to your COVID-19?

Did you stay in hospital due to your COVID-19?

Has your COVID-19 infection got better?